Post Reply
1421-1440 of 1767
Cny $1 :)
lets all huat
new yr 2021, huat bull run
new yr 2021, huat bull run
Hone run come on!
WHAT THE &lsquo UNDECIDED&rsquo CAMP SAY TODAY interviewed 10 healthcare workers from both public and private hospitals. Half of them are undecided about getting the vaccine. Most of them cannot be named as they are not authorised to speak to the media. The healthcare workers who are undecided said they are mostly concerned about whether the vaccine has any possible long-term side effects that are not yet known due to its swift development. They pointed out that there are currently no long-term studies on the Pfizer-BioNTech vaccine that has been approved for use here and much is still unknown about how this vaccine, which uses new messenger ribonucleic acid (mRNA) technology, would affect individuals in the long-run.
Said one nurse from KK Women&rsquo s and Children&rsquo s Hospital (KKH): &ldquo What&rsquo s going to happen to my body in 10 years after I take the vaccine? No one can tell me that.&rdquo
Read more at https://www.todayonline.com/singapore/covid-19-not-all-healthcare-workers-keen-vaccine-now-early-days-some-prefer-wait-and-see
Said one nurse from KK Women&rsquo s and Children&rsquo s Hospital (KKH): &ldquo What&rsquo s going to happen to my body in 10 years after I take the vaccine? No one can tell me that.&rdquo
Read more at https://www.todayonline.com/singapore/covid-19-not-all-healthcare-workers-keen-vaccine-now-early-days-some-prefer-wait-and-see
look@bright ( Date: 12-Jan-2021 22:28) Posted:
|
Three private hospitals here say 50 to 70 per cent of healthcare workers are willing to get vaccination now
TODAY also spoke to some healthcare workers from public and private hospitals
Half of them are undecided about whether to get vaccinated
Those undecided said they are worried about the possible long-term side effects
Those who want to get vaccinated now said they are doing it to protect themselves and their family
Read more at https://www.todayonline.com/singapore/covid-19-not-all-healthcare-workers-keen-vaccine-now-early-days-some-prefer-wait-and-see
TODAY also spoke to some healthcare workers from public and private hospitals
Half of them are undecided about whether to get vaccinated
Those undecided said they are worried about the possible long-term side effects
Those who want to get vaccinated now said they are doing it to protect themselves and their family
Read more at https://www.todayonline.com/singapore/covid-19-not-all-healthcare-workers-keen-vaccine-now-early-days-some-prefer-wait-and-see
look@bright ( Date: 12-Jan-2021 22:26) Posted:
|
Covid-19: Not all healthcare workers keen on vaccine for now &lsquo early days&rsquo as some prefer to wait and see
Read more at https://www.todayonline.com/singapore/covid-19-not-all-healthcare-workers-keen-vaccine-now-early-days-some-prefer-wait-and-see
Read more at https://www.todayonline.com/singapore/covid-19-not-all-healthcare-workers-keen-vaccine-now-early-days-some-prefer-wait-and-see
Once 70 it will start a home run to 1.00
Results nearing and this is a huge catalyst. $1.00 is confirmed.
Just wait and see I am right or not.
Results nearing and this is a huge catalyst. $1.00 is confirmed.
Just wait and see I am right or not.
ss2017. ( Date: 12-Jan-2021 13:44) Posted:
|
Gloves TP by CIMB
Same report on 11th Jan 2021
Riverstone Holdings
ADD, TP S$2.50, S$1.39 close
RSTON sees strong demand in both its
healthcare and cleanroom segments, and
targets healthcare/cleanroom segment
ASP growth of 40%/30% qoq,
respectively, in 4Q20F.
UG Healthcare Corp Ltd
ADD, TP S$1.70, S$0.67 close
The glove shortage remains acute amid a
worsening Covid-19 pandemic crisis.
UGHC said its distribution companies&rsquo
inventories are managed on a very tight
schedule based on just-in-time delivery.
Longtermer ( Date: 12-Jan-2021 13:49) Posted:
|
Rubber Gloves
4QCY20F preview: Another strong showing
CIMB 12 Jan 2021
■ We forecast UGHC and RSTON to report another quarter of record earnings
in 4QCY20F, with net profits jumping 54x/8.5x yoy, respectively.
■ Fundamentals of glovemakers remain strong as ASP uptrend continues,
which could support stronger earnings in quarters ahead.
■ We see value emerging post the removal of share price overhang (lifting of
Bursa&rsquo s short-selling restriction). Maintain Add on UGHC and RSTON.
Fundamentals intact with ASP remaining firmly on an uptrend
We believe fundamentals of glovemakers remain strong in FY21F, as resurgence in Covid- 19 worldwide underpin firm demand for gloves. The Malaysian Rubber Glove Manufacturers Association (MARGMA) estimates that the global glove shortage situation will persist in 2021F, due to increased usage in the medical field as well as in non-medical industries (retail, F& B, etc.). Based on our channel checks, glove ASPs remain firmly on an uptrend, which could support strong earnings in quarters ahead.
UGHC 2QFY6/21F net profit: S$30m (+31% qoq, 54-fold jump yoy)
We forecast UGHC to report net profit of S$30m (+31% qoq, 54-fold increase yoy) in 2QFY6/21F. UGHC said its distribution companies&rsquo inventory levels remain low, and have to be managed on a very tight schedule based on just-in-time delivery.
We estimate that UGHC&rsquo s ASP rose by 10-20% mom in Dec, and will further increase by 5-10% mom in Jan and Feb 2021. We believe further ASP uptrend can be supported by the narrowing price gap for gloves between developing and developed countries.
RSTON 4Q20F net profit: RM275m (+54% qoq, +757% yoy)
We forecast RSTON to report net profit of RM275m (+54% qoq, +757% yoy) in 4Q20. We estimate its healthcare gloves&rsquo ASP grew 10-15% mom in Dec/Jan, and could likely rise by another 5-10% in Feb to c.US$100 per thousand pcs. Cleanroom gloves&rsquo ASP were also raised by 10-15% in Jan, and currently stand at c.US$110 per thousand pcs.
We believe margin expansion trend should continue in coming quarters, as ASP hikes continue to outpace raw material cost increases.
Overhang removed, value emerging
Glovemakers have seen share price correction of c.30% since Nov due to 1) vaccine development newsflow, and subsequently 2) share price overhang from the impending lifting of Bursa Malaysia&rsquo s short-selling suspension on 1 Jan 2021.
Currently, UGHC and RSTON are trading at 5.2x and 9.4x CY22F, respectively, which we think more than prices in earnings normalisation post Covid-19.
We reiterate our Add calls on both UGHC and RSTON, and see upcoming results announcements in Feb as a near-term share price catalyst.
UGHC remains our preferred pick given its relatively cheaper valuation and our expectations of higher normalised profits, backed by a 59% yoy manufacturing capacity expansion expected in CY21F.
4QCY20F preview: Another strong showing
CIMB 12 Jan 2021
■ We forecast UGHC and RSTON to report another quarter of record earnings
in 4QCY20F, with net profits jumping 54x/8.5x yoy, respectively.
■ Fundamentals of glovemakers remain strong as ASP uptrend continues,
which could support stronger earnings in quarters ahead.
■ We see value emerging post the removal of share price overhang (lifting of
Bursa&rsquo s short-selling restriction). Maintain Add on UGHC and RSTON.
Fundamentals intact with ASP remaining firmly on an uptrend
We believe fundamentals of glovemakers remain strong in FY21F, as resurgence in Covid- 19 worldwide underpin firm demand for gloves. The Malaysian Rubber Glove Manufacturers Association (MARGMA) estimates that the global glove shortage situation will persist in 2021F, due to increased usage in the medical field as well as in non-medical industries (retail, F& B, etc.). Based on our channel checks, glove ASPs remain firmly on an uptrend, which could support strong earnings in quarters ahead.
UGHC 2QFY6/21F net profit: S$30m (+31% qoq, 54-fold jump yoy)
We forecast UGHC to report net profit of S$30m (+31% qoq, 54-fold increase yoy) in 2QFY6/21F. UGHC said its distribution companies&rsquo inventory levels remain low, and have to be managed on a very tight schedule based on just-in-time delivery.
We estimate that UGHC&rsquo s ASP rose by 10-20% mom in Dec, and will further increase by 5-10% mom in Jan and Feb 2021. We believe further ASP uptrend can be supported by the narrowing price gap for gloves between developing and developed countries.
RSTON 4Q20F net profit: RM275m (+54% qoq, +757% yoy)
We forecast RSTON to report net profit of RM275m (+54% qoq, +757% yoy) in 4Q20. We estimate its healthcare gloves&rsquo ASP grew 10-15% mom in Dec/Jan, and could likely rise by another 5-10% in Feb to c.US$100 per thousand pcs. Cleanroom gloves&rsquo ASP were also raised by 10-15% in Jan, and currently stand at c.US$110 per thousand pcs.
We believe margin expansion trend should continue in coming quarters, as ASP hikes continue to outpace raw material cost increases.
Overhang removed, value emerging
Glovemakers have seen share price correction of c.30% since Nov due to 1) vaccine development newsflow, and subsequently 2) share price overhang from the impending lifting of Bursa Malaysia&rsquo s short-selling suspension on 1 Jan 2021.
Currently, UGHC and RSTON are trading at 5.2x and 9.4x CY22F, respectively, which we think more than prices in earnings normalisation post Covid-19.
We reiterate our Add calls on both UGHC and RSTON, and see upcoming results announcements in Feb as a near-term share price catalyst.
UGHC remains our preferred pick given its relatively cheaper valuation and our expectations of higher normalised profits, backed by a 59% yoy manufacturing capacity expansion expected in CY21F.
When UG picks up this time, it should surpass old 69 and start a new page 70
ss2017. ( Date: 12-Jan-2021 13:17) Posted:
|
Contra players come and go, nay sayers come and go, short sellers come and go.
UG remains there producing gloves to serve the world communities and at the same time it will report handsome profit and good dividend in due course.
UG remains there producing gloves to serve the world communities and at the same time it will report handsome profit and good dividend in due course.
UG after building a base at 65 over last two days, now it will resume surging momentum
89 cts is still a steep 50% from ir' s natural homing price of 1.77 cts.When the production goal of doublng revenue is reached,it can be a staggering 3.60 stock,all happening in a whiff in 2021.This stock will do quantum leaps not the boring hop,step and jump.
Ushnisambatha ( Date: 10-Jan-2021 16:52) Posted:
|
Just heard CNA news.
Malaysia going to announce new measures on covid19
Malaysia going to announce new measures on covid19
89 cts and climbing. Natural progression,don' t fight it.
look@bright ( Date: 08-Jan-2021 20:27) Posted:
|
Ismail Sabri: PM will announce Malaysia' s next steps, possibility of MCO on Monday (Jan 11)
Ismail Sabri: PM will announce Malaysia' s next steps, possibility of MCO on Monday (Jan 11) | The StarAgree.. should have more upside.
Glove companies stock prices likely to trend back up as gloves demands are not going away for a while. All productions are pre committed with high ASPs.
Waiting time are Surgical glove is 250 days, Nitrile glove 560 days ( from TG slides)
UG is one of the most undervalued glove player imo.
TP around 1.35 to 1.70 by Phillips and CIMB i think.
Upside avg about 128%.. Dyodd.
lsyiat ( Date: 08-Jan-2021 17:00) Posted:
|
Look forward to hit 85c soon !?
lsyiat ( Date: 08-Jan-2021 17:18) Posted:
|
Anyway Supermax eyes listing on Singapore Exchange, I believe its best indicator for UG movement next time
https://www.theedgemarkets.com/article/supermax-eyes-listing-singapore-exchange
https://www.theedgemarkets.com/article/supermax-eyes-listing-singapore-exchange
lsyiat ( Date: 08-Jan-2021 17:00) Posted:
|
Peer of UG listed in KLSE, also OBM player
Supermax +20.66%
Careplus +28.26%
UG +10.74% , should be more upside today
Supermax +20.66%
Careplus +28.26%
UG +10.74% , should be more upside today